Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Boston Scientific, Medtronic Heart Devices Go To Panel In March

This article was originally published in The Gray Sheet

  • News

Executive Summary

FDA's Circulatory System Devices advisory panel will weigh in on two closely watched approval decisions at a March 18-19 meeting

You may also be interested in...



Medtronic Spine Sales Down In Fiscal Q3, But Firm Expects A Rebound In 2011

Medtronic is looking to turn around its flagging spine business by mid-2011, CEO Bill Hawkins said during the firm's Feb. 23 fiscal third quarter earnings call

Medtronic Spine Sales Down In Fiscal Q3, But Firm Expects A Rebound In 2011

Medtronic is looking to turn around its flagging spine business by mid-2011, CEO Bill Hawkins said during the firm's Feb. 23 fiscal third quarter earnings call

Boston Scientific CRM In 2010: Steep Challenges, Some Prospects

Sales force firings and perceived product design issues are adding to an already challenging cardiac rhythm management picture for Boston Scientific in 2010

Table

View full table

Related Content

Medtech Insight
Medtech Insight

Topics

Tags:
Medical Device
Latest Headlines

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations

See All
UsernamePublicRestriction

Register

MT028519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By